HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mark Shlapobersky Selected Research
Mark Shlapobersky Research Topics
Disease
4
Infections
11/2012 - 10/2006
2
Herpes Genitalis (Genital Herpes)
11/2012 - 06/2012
1
Plasmacytoma
01/2022
1
Clinical Deterioration
01/2022
1
Rare Diseases (Rare Disease)
01/2022
1
Hematologic Diseases (Blood Diseases)
01/2022
1
Testicular Neoplasms (Testicular Cancer)
01/2020
1
Neoplasms (Cancer)
01/2020
1
Skin Diseases (Skin Disease)
11/2012
1
Cytomegalovirus Infections (Inclusion Disease)
11/2012
1
Herpes Simplex
06/2012
1
Human Influenza (Influenza)
10/2009
Drug/Important Bio-Agent (IBA)
4
Vaccines
IBA
11/2012 - 10/2009
4
vaxfectin
IBA
11/2012 - 10/2009
3
Antigens
IBA
01/2020 - 10/2009
2
DNA Vaccines
IBA
11/2012 - 06/2012
2
Lipids
IBA
11/2012 - 10/2009
2
Proteins (Proteins, Gene)
FDA Link
11/2012 - 10/2009
2
DNA (Deoxyribonucleic Acid)
IBA
11/2012 - 06/2012
1
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2020
1
Neoplasm Antigens (Tumor Antigens)
IBA
01/2020
1
Therapeutic Uses
IBA
11/2012
1
glycoprotein D-herpes simplex virus type 2
IBA
11/2012
1
Glycoproteins (Glycoprotein)
IBA
06/2012
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
02/2011
1
Horseradish Peroxidase
IBA
02/2011
1
Luminol
IBA
02/2011
1
Cyclin A
IBA
10/2006
1
Transcription Factors (Transcription Factor)
IBA
10/2006
Therapy/Procedure
1
Drug Therapy (Chemotherapy)
01/2022
1
Gastrectomy
01/2022
1
Immunotherapy
01/2020